162 related articles for article (PubMed ID: 23893437)
1. Immunohistochemical studies of metastatic germ-cell tumors in retroperitoneal dissection specimens: a sensitive and specific panel.
Bai S; Wei S; Pasha TL; Yao Y; Tomaszewski JE; Bing Z
Int J Surg Pathol; 2013 Aug; 21(4):342-51. PubMed ID: 23893437
[TBL] [Abstract][Full Text] [Related]
2. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
Cao D; Li J; Guo CC; Allan RW; Humphrey PA
Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
[TBL] [Abstract][Full Text] [Related]
4. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
5. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
Cao D; Humphrey PA; Allan RW
Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
[TBL] [Abstract][Full Text] [Related]
6. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
7. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II alpha expression in testicular germ cell tumors.
Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
11. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
12. "Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.
Magers MJ; Kao CS; Cole CD; Rice KR; Foster RS; Einhorn LH; Ulbright TM
Am J Surg Pathol; 2014 Oct; 38(10):1396-409. PubMed ID: 24921638
[TBL] [Abstract][Full Text] [Related]
13. Expression of glypican 3 in ovarian and extragonadal germ cell tumors.
Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ
Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091
[TBL] [Abstract][Full Text] [Related]
14. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
15. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.
Iczkowski KA; Butler SL; Shanks JH; Hossain D; Schall A; Meiers I; Zhou M; Torkko KC; Kim SJ; MacLennan GT
Hum Pathol; 2008 Feb; 39(2):275-81. PubMed ID: 18045648
[TBL] [Abstract][Full Text] [Related]
16. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
Yu H; Pinkus GS; Hornick JL
Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198
[TBL] [Abstract][Full Text] [Related]
17. The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.
Miller JS; Lee TK; Epstein JI; Ulbright TM
Am J Surg Pathol; 2009 Sep; 33(9):1293-8. PubMed ID: 19461507
[TBL] [Abstract][Full Text] [Related]
18. [Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].
Kashiwagi A
Hokkaido Igaku Zasshi; 1992 Nov; 67(6):801-14. PubMed ID: 1336479
[TBL] [Abstract][Full Text] [Related]
19. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
Lau SK; Weiss LM; Chu PG
Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
[TBL] [Abstract][Full Text] [Related]
20. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Emerson RE; Ulbright TM
Pathology; 2010 Jun; 42(4):344-55. PubMed ID: 20438407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]